Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression
Authors:
- Azra RazaARAzra Raza
- Silvia BuonamiciSBSilvia Buonamici
- Laurie LisakLLLaurie Lisak
- Sarah TahirSTSarah Tahir
- Donglan LiDLDonglan Li
- Mehnaz ImranMIMehnaz Imran
- Nusrat Ijaz ChaudaryNCNusrat Ijaz Chaudary
- Hassan PervaizHPHassan Pervaiz
- J.Alejandro GallegosJGJ.Alejandro Gallegos
- M.Imran AlviMAM.Imran Alvi
- Muhammad MumtazMMMuhammad Mumtaz
- Sefer GezerSGSefer Gezer
- 1 August 2004
- journal article
- case report
- Published by Elsevier in Leukemia Research
- Vol. 28 (8) , 791-803
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- The myelodysplastic syndrome(s): a perspective and review highlighting current controversiesLeukemia Research, 2003
- Interaction of EVI1 with cAMP-responsive Element-binding Protein-binding Protein (CBP) and p300/CBP-associated Factor (P/CAF) Results in Reversible Acetylation of EVI1 and in Co-localization in Nuclear SpecklesJournal of Biological Chemistry, 2001
- Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromesBlood, 2001
- Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromesBlood, 2001
- Hematopoietic stem cell transplantation in patients with myelodysplastic syndromeLeukemia Research, 2000
- Human AML1/MDS1/EVI1 fusion protein induces an acute myelogenous leukemia (AML) in mice: A model for human AMLProceedings of the National Academy of Sciences, 2000
- MDS1/EVI1 enhances TGF-β1 signaling and strengthens its growth-inhibitory effect, but the leukemia-associated fusion protein AML1/MDS1/EVI1, product of the t(3;21), abrogates growth-inhibition in response to TGF-β1Leukemia, 1999
- The EVI1 gene in myeloid leukemiaLeukemia, 1997
- Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family.Proceedings of the National Academy of Sciences, 1996
- Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell linesCell, 1988